ABL Diagnostics to Become Exclusive Distributor of VELADX in EMEA for Molecular Diagnostics
WOIPPY, FRANCE, July 29, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the signing of an exclusive distribution agreement with VELA …